by Life Science Newswire | Dec 18, 2019 | Corporate, Finance & Investor, Drug Discovery & Development, Pharma
The financing will accelerate the development of first-in-class therapies in autoimmune disease and immuno-oncology Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer,...
by Life Science Newswire | Dec 17, 2019 | Analytical Chemistry, Clinical Research & Trials, Computing & Technology, Diagnostics & Hospital Laboratory, Drug Discovery & Development, Energy & Environment, General Chemistry, General Laboratory, General Science, Healthcare, Materials Science, Microbiology & Infection Control, Microscopy & Imaging, Pharma, Water
Climate crisis, artificial intelligence, and vaccines top the list of 2019’s most discussed research From the increasing use of artificial intelligence to the climate emergency facing us all, many of this year’s most polarizing issues feature in the Altmetric Top 100,...
by Life Science Newswire | Dec 12, 2019 | Corporate, Finance & Investor, Drug Discovery & Development, Pharma
TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, has today announced its corporate name change to SPT Labtech effective from January 6, 2020. The change of name is a contractual...
by Life Science Newswire | Dec 11, 2019 | Clinical Research & Trials, Corporate, Finance & Investor, Diagnostics & Hospital Laboratory, Pharma
Inceptua announced today that Stefan Fraenkel has been appointed CEO effective 1 January 2020. Alan Raffensperger is appointed Executive Vice-Chairman of the Inceptua Group. Inceptua – a pharmaceutical company and service partner spanning throughout the product...
by Life Science Newswire | Dec 9, 2019 | Clinical Research & Trials, Healthcare, Pharma
Onconova Therapeutics, Inc., a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), and Inceptua Medicines Access (a business unit of the Inceptua Group), a global...
